Teva Pharmaceutical (TEVA) lagged Wall Street's third-quarter earnings forecast, but Teva stock rallied early Thursday after the company boosted its full-year outlook.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,